DoubleLine ETF Adviser LP

Mutual Fund

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1959989 Tampa, FL

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$753,859

-$262,935 QoQ

Shares Held

1,209

-8.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

#711

of 1,322 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DoubleLine ETF Adviser LP holds $2,688,568 across 4 Biotechnology names. REGN ranks #2 (28.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,949	$1,464,856
2	REGN	Regeneron Pharmaceuticals, Inc. This page	1,209	$753,859
3	MRNA	Moderna, Inc.	3,760	$263,312
4	INCY	Incyte Corp	1,822	$206,541

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$753,859	1,209	-8.1%	Shares	Sole	2026-08-14
2026-03-31	$1,016,794	1,316	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.